|
Dr. Ronald Levy’s landmark research on the basic immuno-biology of lymphocytes and on monoclonal antibodies led to the development of rituximab, a widely successful treatment for B-cell lymphoma. Dr. Levy continues to study the mechanism of lymphoma initiation and progression to develop new monoclonal and vaccine therapies for this disease. Dr. Levy has received numerous honors and awards, including the Damashek Prize from the American Society of Hematology in 2004, the Jeffrey A. Gottlieb Memorial Award from the M.D. Anderson Cancer Center in 2003, the Evelyn Hoffman Memorial Award from the Lymphoma Research Foundation of America in 2001 and the Medal of Honor from the American Cancer Society in 2000. | 